Paul R. Rhomberg

7.9k total citations
188 papers, 6.3k citations indexed

About

Paul R. Rhomberg is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Paul R. Rhomberg has authored 188 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 80 papers in Epidemiology and 73 papers in Molecular Medicine. Recurrent topics in Paul R. Rhomberg's work include Antibiotic Resistance in Bacteria (73 papers), Antibiotics Pharmacokinetics and Efficacy (53 papers) and Antifungal resistance and susceptibility (41 papers). Paul R. Rhomberg is often cited by papers focused on Antibiotic Resistance in Bacteria (73 papers), Antibiotics Pharmacokinetics and Efficacy (53 papers) and Antifungal resistance and susceptibility (41 papers). Paul R. Rhomberg collaborates with scholars based in United States, Austria and Germany. Paul R. Rhomberg's co-authors include Ronald N. Jones, Hélio S. Sader, Michael A. Pfaller, Mariana Castanheira, Robert K. Flamm, S. A. Messer, Gary V. Doern, Holly K. Huynh, Angela B. Brueggemann and David J. Farrell and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Paul R. Rhomberg

184 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul R. Rhomberg United States	45	2.7k	2.2k	2.1k	1.9k	752	188	6.3k
Ludwig Gutmann United States	49	1.8k 0.7×	2.1k 1.0×	1.8k 0.9×	1.3k 0.7×	1.5k 2.1×	260	7.5k
Min Ja Kim South Korea	35	1.6k 0.6×	844 0.4×	1.1k 0.5×	492 0.3×	791 1.1×	224	4.4k
Cornelia B. Landersdorfer Australia	36	1.2k 0.5×	2.3k 1.0×	456 0.2×	2.2k 1.2×	653 0.9×	150	4.4k
Sally Roberts New Zealand	38	1.8k 0.6×	500 0.2×	2.3k 1.1×	526 0.3×	597 0.8×	163	4.7k
Daniel J. Morgan United States	37	762 0.3×	662 0.3×	1.1k 0.5×	637 0.3×	665 0.9×	138	4.5k
Robert J. Fass United States	36	1.3k 0.5×	771 0.3×	1.5k 0.7×	955 0.5×	411 0.5×	142	4.0k
Hannah M. Wexler United States	33	675 0.3×	809 0.4×	1.4k 0.7×	515 0.3×	2.3k 3.1×	116	5.3k
John P. Dekker United States	31	795 0.3×	1.5k 0.7×	481 0.2×	405 0.2×	980 1.3×	85	3.5k
W. Michael Scheld United States	32	2.0k 0.8×	397 0.2×	1.6k 0.8×	644 0.3×	524 0.7×	92	4.6k
Yutaka Tamura Japan	41	500 0.2×	1.4k 0.6×	1.3k 0.6×	412 0.2×	1.3k 1.7×	268	5.6k

Countries citing papers authored by Paul R. Rhomberg

Since Specialization

Citations

This map shows the geographic impact of Paul R. Rhomberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Rhomberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Rhomberg more than expected).

Fields of papers citing papers by Paul R. Rhomberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Rhomberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Rhomberg. The network helps show where Paul R. Rhomberg may publish in the future.

Co-authorship network of co-authors of Paul R. Rhomberg

This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Rhomberg. A scholar is included among the top collaborators of Paul R. Rhomberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Rhomberg. Paul R. Rhomberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maher, Joshua, Michael D. Huband, Paul R. Rhomberg, et al.. (2025). Characterization of sulopenem antimicrobial activity using in vitro time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against Escherichia coli and Klebsiella pneumoniae isolates. Microbiology Spectrum. 13(3). e0189824–e0189824. 1 indexed citations

Winkler, Marisa, et al.. (2024). Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus using CLSI methods and interpretive criteria. Journal of Clinical Microbiology. 63(2). e0120724–e0120724. 2 indexed citations

Reidenberg, Bruce E., Stephen G. Jenkins, Jared L. Crandon, et al.. (2024). In vitro activity of taurolidine against clinical Candida auris isolates: relevance to catheter-related bloodstream infections. Antimicrobial Agents and Chemotherapy. 68(7). e0038124–e0038124. 1 indexed citations

Winkler, Marisa, et al.. (2024). The In Vitro Activity of Rezafungin Against Uncommon Species of Candida. Mycoses. 67(11). e70001–e70001. 4 indexed citations

Carvalhaes, Cecília G, Paul R. Rhomberg, Michael D. Huband, Michael A. Pfaller, & Mariana Castanheira. (2023). Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific. Journal of Fungi. 9(2). 241–241. 6 indexed citations

Huang, David B., et al.. (2021). In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018. Journal of Global Antimicrobial Resistance. 25. 14–17.

Pfaller, Michael A., Cecília G Carvalhaes, Paul R. Rhomberg, S. A. Messer, & Mariana Castanheira. (2021). Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019). The Journal of Antibiotics. 74(8). 519–527. 14 indexed citations

Pfaller, Michael A., Cecília G Carvalhaes, S. A. Messer, Paul R. Rhomberg, & Mariana Castanheira. (2021). In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years. Diagnostic Microbiology and Infectious Disease. 101(3). 115473–115473. 12 indexed citations

Mendes, Rodrigo E., Paul R. Rhomberg, Troy Lister, et al.. (2019). Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. Microbial Drug Resistance. 26(4). 319–328. 10 indexed citations

10.

Pfaller, Michael A., Hélio S. Sader, Paul R. Rhomberg, Robert K. Flamm, & Rodrigo E. Mendes. (2019). In Vitro Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant Staphylococcus aureus (2014–2015) in the United States. Microbial Drug Resistance. 25(6). 938–943. 9 indexed citations

11.

Rhomberg, Paul R.. (2008). Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design. 46th Annual Meeting. 2 indexed citations

12.

Castanheira, Mariana, Rodrigo E. Mendes, Paul R. Rhomberg, & Ronald N. Jones. (2008). Rapid Emergence of bla _CTX-M Among Enterobacteriaceae in U.S. Medical Centers: Molecular Evaluation from the MYSTIC Program (2007). Microbial Drug Resistance. 14(3). 211–216. 74 indexed citations

13.

Rhomberg, Paul R. & Ronald N. Jones. (2006). Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005). Diagnostic Microbiology and Infectious Disease. 57(2). 207–215. 41 indexed citations

14.

Sader, Hélio S., Paul R. Rhomberg, & Ronald N. Jones. (2005). In Vitro Activity of β-Lactam Antimicrobial Agents in Combination with Aztreonam Tested Against Metallob-β-Lactamase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii. Journal of Chemotherapy. 17(6). 622–627. 16 indexed citations

15.

Deshpande, Lalitagauri M., Paul R. Rhomberg, Thomas R. Fritsche, Hélio S. Sader, & Ronald N. Jones. (2004). Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates. Diagnostic Microbiology and Infectious Disease. 50(1). 73–75. 41 indexed citations

16.

Rhomberg, Paul R.. (2003). Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres. International Journal of Antimicrobial Agents. 23(1). 52–59. 30 indexed citations

17.

Jones, Ronald N., et al.. (2002). Tiamulin Activity against Fastidious and Nonfastidious Veterinary and Human Bacterial Isolates: Initial Development of In Vitro Susceptibility Test Methods. Journal of Clinical Microbiology. 40(2). 461–465. 22 indexed citations

18.

Mathai, Dilip, Paul R. Rhomberg, Douglas J. Biedenbach, & Ronald N. Jones. (2002). Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagnostic Microbiology and Infectious Disease. 44(4). 367–377. 58 indexed citations

19.

Andrews, Janet I., Daniel J. Diekema, Stephen K. Hunter, et al.. (2000). Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. American Journal of Obstetrics and Gynecology. 183(4). 859–862. 87 indexed citations

20.

Doern, Gary V., et al.. (1999). Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98. Emerging infectious diseases. 5(6). 757–765. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact